亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Trends in Complications and Outcomes in Patients Aged 65 Years and Younger Undergoing Total Knee Arthroplasty: Data From the American Joint Replacement Registry

医学 生存曲线 共病 查尔森共病指数 关节置换术 外科 单变量分析 回顾性队列研究 人口
作者
Akash Shah,David Alexander Cieremans,James Slover,Ran Schwarzkopf,Morteza Meftah
出处
期刊:Journal of the American Academy of Orthopaedic Surgeons [Wolters Kluwer]
卷期号:6 (6)
标识
DOI:10.5435/jaaosglobal-d-22-00116
摘要

The purpose of this study was to identify common complications and the rates of readmission and revision in total knee arthroplasty (TKA) patients younger than 65 years.Using the American Joint Replacement Registry, we conducted a retrospective review of all TKAs done in patients aged 18 to 65 years from 2012 to 2020. Demographic factors such as age, sex, Charlson Comorbidity Index (CCI), and preoperative Veterans RAND 12-Item Health Survey Physical Component Summary (VR-12 PCS) scores were collected. We excluded patients older than 65 years and revision, oncologic, and nonelective cases. Primary outcomes included cumulative revision rate, 90-day readmission rate, and reason for revision. Univariate analysis and the Kaplan-Meier method were used.Six thousand one hundred seventy-nine patients were included. The average age was 58.8 years (SD 5.5 years), 61% were female, 82% were White, and 88% had a CCI of 0 (1 = 8% and ≥2 = 4%). The mean follow-up was 42.51 months. Seventy-four patients (1.2%) underwent revision. Sixty-nine patients (1.1%) were readmitted within 90 days. No factors assessed increased revision rates. Revision-free survivorship was 98.7% (95% CI 98.4 to 99.0) and 98.6% (95% CI 98.2 to 99.0) at 5 and 8 years, respectively. Infection (15%), aseptic loosening (14%), and instability (12%) were the most common indications for revision.TKA done in young and presumed active patients has excellent survivorship. Long-term follow-up is needed to assess survival trends in this growing population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzzzzzhu发布了新的文献求助10
3秒前
yh完成签到,获得积分10
11秒前
甘川完成签到 ,获得积分10
13秒前
小橙子发布了新的文献求助10
17秒前
24秒前
25秒前
GGBond发布了新的文献求助10
29秒前
橘x应助科研通管家采纳,获得30
32秒前
科研通AI2S应助科研通管家采纳,获得10
32秒前
香蕉觅云应助科研通管家采纳,获得10
32秒前
橘x应助科研通管家采纳,获得10
32秒前
32秒前
小橙子完成签到,获得积分10
33秒前
科研通AI2S应助疯狂的曼香采纳,获得10
34秒前
zzzzzzhu完成签到,获得积分10
35秒前
善学以致用应助开心采纳,获得50
43秒前
44秒前
45秒前
刘标发布了新的文献求助10
48秒前
50秒前
疯狂的曼香完成签到,获得积分10
1分钟前
1分钟前
南湾不夏发布了新的文献求助10
1分钟前
雪松完成签到 ,获得积分10
1分钟前
小张不爱学习完成签到,获得积分20
1分钟前
拒绝去偏旁完成签到 ,获得积分10
1分钟前
科目三应助南湾不夏采纳,获得10
1分钟前
彭于晏应助流沙无言采纳,获得10
1分钟前
田様应助你的夏至不挽留采纳,获得10
1分钟前
Rn完成签到 ,获得积分0
1分钟前
茉莉完成签到,获得积分20
1分钟前
完美世界应助ZJPPPP采纳,获得10
1分钟前
1分钟前
yu完成签到,获得积分10
1分钟前
茉莉关注了科研通微信公众号
1分钟前
1分钟前
叶菩提完成签到,获得积分10
1分钟前
1分钟前
Negan完成签到,获得积分10
1分钟前
帅气凝云完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6050610
求助须知:如何正确求助?哪些是违规求助? 7846601
关于积分的说明 16266456
捐赠科研通 5195827
什么是DOI,文献DOI怎么找? 2780206
邀请新用户注册赠送积分活动 1763220
关于科研通互助平台的介绍 1645162